Loading...
Please wait, while we are loading the content...
Similar Documents
Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage.
| Content Provider | Semantic Scholar |
|---|---|
| Author | Knauf, Claude Cani, Patrice D. Perrin, Christophe Iglesias, Miguel Angel Maury, Jean François Bernard, Elodie Benhamed, Fadilha Grémeaux, Thierry Drucker, Daniel J. Kahn, C. Ronald Girard, Jean Claude Tanti, Jean François Delzenne, Nathalie M. Postic, Catherine Burcelin, Remy |
| Copyright Year | 2005 |
| Abstract | Intestinal glucagon-like peptide-1 (GLP-1) is a hormone released into the hepatoportal circulation that stimulates pancreatic insulin secretion. GLP-1 also acts as a neuropeptide to control food intake and cardiovascular functions, but its neural role in glucose homeostasis is unknown. We show that brain GLP-1 controlled whole-body glucose fate during hyperglycemic conditions. In mice undergoing a hyperglycemic hyperinsulinemic clamp, icv administration of the specific GLP-1 receptor antagonist exendin 9-39 (Ex9) increased muscle glucose utilization and glycogen content. This effect did not require muscle insulin action, as it also occurred in muscle insulin receptor KO mice. Conversely, icv infusion of the GLP-1 receptor agonist exendin 4 (Ex4) reduced insulin-stimulated muscle glucose utilization. In hyperglycemia achieved by i.v. infusion of glucose, icv Ex4, but not Ex9, caused a 4-fold increase in insulin secretion and enhanced liver glycogen storage. However, when glucose was infused intragastrically, icv Ex9 infusion lowered insulin secretion and hepatic glycogen levels, whereas no effects of icv Ex4 were observed. In diabetic mice fed a high-fat diet, a 1-month chronic i.p. Ex9 treatment improved glucose tolerance and fasting glycemia. Our data show that during hyperglycemia, brain GLP-1 inhibited muscle glucose utilization and increased insulin secretion to favor hepatic glycogen stores, preparing efficiently for the next fasting state. |
| Starting Page | 938 |
| Ending Page | 938 |
| Page Count | 1 |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | http://www.farm.ucl.ac.be/Full-texts-FARM/Knauf-2005-1.pdf |
| Alternate Webpage(s) | http://dm5migu4zj3pb.cloudfront.net/manuscripts/25000/25764/JCI0525764.pdf |
| PubMed reference number | 16322793v1 |
| Volume Number | 115 |
| Issue Number | 12 |
| Journal | The Journal of clinical investigation |
| Language | English |
| Access Restriction | Open |
| Subject Keyword | Blood Glucose Diabetes Mellitus Diet, High-Fat Eating Glucagon Glucagon-Like Peptide 1 Glucagon-Like Peptide-1 Receptor Glucose Metabolism Disorders Hyperglycemia Hyperinsulinism Insulin Resistance Interleukin Receptor Common gamma Subunit Liver Glycogen Liver diseases Muscle Neuropeptides Preparation exenatide glucose tolerance insulin secretion |
| Content Type | Text |
| Resource Type | Article |
